UBVAX (UBVAX) Stock Price & Analysis
UBVAX (UBVAX) rose 0.00% to USD 86.67 as of July 26, 2026 at 01:30 UTC, according to Nexqual real-time market data.
UBVAX last closed at USD 86.67; the session ranged USD 86.67–86.67 on volume of 0 shares. Market capitalization is —, with a 52-week range of USD 74.91–87.82 (NAS). Source: Nexqual, July 26, 2026 at 01:30 UTC.
Key Statistics (as of July 26, 2026 at 01:30 UTC)
| Price | USD 86.67 |
|---|---|
| Change | ▲ 0.00% (up) |
| Previous Close | USD 86.67 |
| Open | USD 86.67 |
| Day Range | USD 86.67 – 86.67 |
| 52-Week Range | USD 74.91 – 87.82 |
| Volume | 0 shares |
| Market Cap | — |
| Exchange | NAS |
Technical Analysis (UBVAX)
Nexqual's technical model rates UBVAX "STRONG BUY" based on 5 bullish and 0 bearish signals across 125 daily candles, as of July 26, 2026 at 01:30 UTC.
| Overall Signal | STRONG BUY |
|---|---|
| RSI (14) | 60.63 (neutral) |
| vs SMA50 | Above (USD 82.87) |
| MACD | 1 (positive) |
Peers & Related Stocks
| Symbol | Name | Price | Change |
|---|---|---|---|
| UBVLX | Undiscovered Managers Behaviora | USD 90.27 | ▲ 0.33% |
| JVAAX | JPMorgan Value Advantage Class | USD 40.68 | ▲ 0.57% |
| UBVSX | Undiscovered Managers Behaviora | USD 89.73 | ▲ 0.32% |
| OIEIX | JPMorgan Equity Income Fund A | USD 27.73 | ▲ 0.29% |
| VHIAX | JPMorgan Growth Advantage Fund | USD 38.45 | ▼ 2.66% |
Data source: Nexqual — real-time market data, technical indicators, analyst consensus, earnings, SEC EDGAR filings. Last updated: July 26, 2026 at 01:30 UTC. This page is informational and not investment advice.